| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.33 | 1e-19 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.31 | 5e-15 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.27 | 1e-12 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.33 | 2e-11 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.21 | 9e-07 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-06 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-06 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-05 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.22 | 8e-05 |